Empagliflozin benefits heart failure patients with reduced and preserved ejection fraction
EMPEROR-Pooled analysis presented in a Hot Line Session today at ESC Congress 2021 A pooled analysis of two randomised trials has demonstrated the beneficial effects of empagliflozin in patients with…